GluN2A antagonists (Seed Therapeutics/Janssen R&D)

N/A

Report date: 2025/06/11 10:30:34
NME

Base Information

Drug NameGluN2A antagonists (Seed Therapeutics/Janssen R&D)
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionGlutamate receptor ionotropic, NMDA 2A inhibitorsNeuroprotectants
TargetsGlutamate receptor ionotropic, NMDA 2A
Therapy Area/IndicationsCentral Nervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSeed Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesSeed Therapeutics IncJanssen Research & Development Llc
Inactive CompaniesN/A
Active IndicationsCentral Nervous System Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A